" class="no-js "lang="en-US"> Digital Robotic Technology for Knee Replacement Surgery Available for Duly Health and Care Patients - Medtech Alert
Tuesday, June 18, 2024

Digital Robotic Technology for Knee Replacement Surgery Available for Duly Health and Care Patients

As more people seek ways to stay active, healthy, and mobile, Duly Health and Care today announced the availability of advanced digital robotic technology at Duly Surgery Center Westmont.

According to the American Academy of Orthopedic Surgeons, more than one in two adults—124 million Americans over the age of 18, reported a musculoskeletal medical condition. That exceeds the next two most common health conditions: circulatory conditions (such as heart disease, stroke, and hypertension) and respiratory conditions (such as emphysema and chronic asthma).

“This is the latest technology available for us to ensure our patients are getting the very best when it comes to joint replacement surgery,” said Antho­ny Romeo, MD, Exec­u­tive Vice Pres­i­dent and orthopedic surgeon for Duly Health and Care. “The robotic technology will help our orthopedic surgeons perform joint replacement with more precision, consistency, and accuracy resulting in better health outcomes so patients can return to the activities they enjoy.”

The VELYS™ Robotic-Assisted Solution helps surgeons perform a knee replacement with the use of data that is tailored to each patient’s anatomy. It is designed to help ensure predictable results to improve health outcomes, increase mobility, and help patients recover faster.

“With the data from this technology, we will be able to correlate measurements with patient recovery and outcomes and learn more about how to continue to deliver the best care,” added Dr. Romeo.

Duly Surgery Center Westmont, located at 815 Pasquinelli Drive, is an advanced Ambulatory Surgical Center (ASC) dedicated to providing outpatient orthopedic and spine surgery procedures. Board-certified orthopedic surgeons at the ASC are trained in the latest surgical advancements, such as total joint replacement surgeries, spine surgeries and sports medicine-related procedures. Click here to learn more about the ASC.

Companies In This Post

  1. Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
  2. Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
  3. DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
  4. Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
  5. Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more